Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11304)
All Articles published online
|
Publishing Process of This Article
|
Apr 12, 2014 (publication date) through Nov 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Translational Medicine
ISSN
2220-6132
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Desai A, Xu J, Aysola K, Qin Y, Okoli C, Hariprasad R, Chinemerem U, Gates C, Reddy A, Danner O, Franklin G, Ngozi A, Cantuaria G, Singh K, Grizzle W, Landen C, Partridge EE, Rice VM, Reddy ESP, Rao VN. Epithelial ovarian cancer: An overview. World J Transl Med 2014; 3(1): 1-8 [PMID: 25525571 DOI: 10.5528/wjtm.v3.i1.1] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6132/full/v3/i1/1.htm |
| Number | Citing Articles |
| 1 |
Clarissa L. Velayo, Kareen N. Reforma, Renee Vina G. Sicam, Michele H. Diwa, Alvin Duke R. Sy, Ourlad Alzeus G. Tantengco. Clinical Performance of a Multivariate Index Assay in Detecting Early-Stage Ovarian Cancer in Filipino Women. International Journal of Environmental Research and Public Health 2022; 19(16): 9896 doi: 10.3390/ijerph19169896
|
| 2 |
Giovanni Tossetta, Sonia Fantone, Gaia Goteri, Stefano Raffaele Giannubilo, Andrea Ciavattini, Daniela Marzioni. The Role of NQO1 in Ovarian Cancer. International Journal of Molecular Sciences 2023; 24(9): 7839 doi: 10.3390/ijms24097839
|
| 3 |
Tomor Harnod, I-Ju Tsai, Weishan Chen, Jen-Hung Wang, Shinn-Zong Lin, Fung-Chang Sung, Dah-Ching Ding. Hysterectomy and unilateral salpingectomy associate with a higher risk of subsequent ovarian cancer. Medicine 2019; 98(48): e18058 doi: 10.1097/MD.0000000000018058
|
| 4 |
Zachary R. Visco, Gregory Sfakianos, Carole Grenier, Marie-Helene Boudreau, Sabrina Simpson, Isabel Rodriguez, Regina Whitaker, Derek Y. Yao, Andrew Berchuck, Susan K. Murphy, Zhiqing Huang. Epigenetic Regulation of Claudin-1 in the Development of Ovarian Cancer Recurrence and Drug Resistance. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.620873
|
| 5 |
Varsha Ginnavaram, Arumugam Vasugi, Sandhya Sundaram. Immunohistochemical Evaluation of Notch1 in Ovarian Tumours and Its Prognostic Implications. Cureus 2023; doi: 10.7759/cureus.40830
|
| 6 |
Fabrizio Fontana, Monica Marzagalli, Michela Raimondi, Valentina Zuco, Nadia Zaffaroni, Patrizia Limonta. δ‐Tocotrienol sensitizes and re‐sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK‐mediated apoptosis. Cell Proliferation 2021; 54(11) doi: 10.1111/cpr.13111
|
| 7 |
Roberto Maggi, Anna Maria Cariboni, Marina Montagnani Marelli, Roberta Manuela Moretti, Valentina Andrè, Monica Marzagalli, Patrizia Limonta. GnRH and GnRH receptors in the pathophysiology of the human female reproductive system. Human Reproduction Update 2016; 22(3): 358 doi: 10.1093/humupd/dmv059
|
| 8 |
Saul N. Friedman, Malak Itani, Farrokh Dehdashti. PET Imaging for Gynecologic Malignancies. Radiologic Clinics of North America 2021; 59(5): 813 doi: 10.1016/j.rcl.2021.05.011
|
| 9 |
Ting-Ting Gong, Shuang Guo, Fang-Hua Liu, Yun-Long Huo, Meng Zhang, Shi Yan, Han-Xiao Zhou, Xu Pan, Xin-Yue Wang, He-Li Xu, Ye Kang, Yi-Zi Li, Xue Qin, Qian Xiao, Dong-Hui Huang, Xiao-Ying Li, Yue-Yang Zhao, Xin-Xin Zhao, Ya-Li Wang, Xiao-Xin Ma, Song Gao, Yu-Hong Zhao, Shang-Wei Ning, Qi-Jun Wu. Proteomic characterization of epithelial ovarian cancer delineates molecular signatures and therapeutic targets in distinct histological subtypes. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-43282-3
|
| 10 |
Arkene Levy, Carolina Leynes, Mirza Baig, Sue Anne Chew. The Application of Biomaterials in the Treatment of Platinum‐Resistant Ovarian Cancer. ChemMedChem 2019; 14(21): 1810 doi: 10.1002/cmdc.201900450
|
| 11 |
Sunita B Patil, Suman Saurabh Gupta, Suchita V Deshmukh, Seema S More. A rare case of bilateral mucinous cystadenocarcinoma of ovary mimicking endometriotic ovarian cyst on radiology. IP Journal of Diagnostic Pathology and Oncology 2020; 5(1): 118 doi: 10.18231/j.jdpo.2020.025
|
| 12 |
Ngoc Le Tran, Yao Wang, Maree Bilandzic, Andrew Stephens, Guiying Nie. Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-57053-7
|
| 13 |
Woo Yeon Hwang, Minjung Lee, Dong Hoon Suh, Kidong Kim, Jae Hong No, Yong Beom Kim, Ju-Hyun Kim. Risk factors for and prognosis of carboplatin-related hypersensitivity in patients with epithelial ovarian cancer. Archives of Gynecology and Obstetrics 2022; 306(2): 443 doi: 10.1007/s00404-022-06403-9
|
| 14 |
Yu-Fa Su, Eing-Mei Tsai, Chih-Chieh Chen, Chun-Chieh Wu, Tze-Kiong Er. Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma. Clinica Chimica Acta 2019; 494: 1 doi: 10.1016/j.cca.2019.03.003
|
| 15 |
Yuxia Bao, Bin Yang, Jingjiao Zhao, Simin Shen, Jianyuan Gao. Role of common ERCC1 polymorphisms in cisplatin‐resistant epithelial ovarian cancer patients: A study in Chinese cohort. International Journal of Immunogenetics 2020; 47(5): 443 doi: 10.1111/iji.12484
|
| 16 |
Komal Tyagi, Adhiraj Roy, Supratim Mandal. Protein kinase C iota promotes glycolysis via PI3K/AKT/mTOR signalling in high grade serous ovarian cancer. Molecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-024-09918-3
|
| 17 |
Medi Kori, Talip Yasir Demirtas, Betul Comertpay, Kazim Yalcin Arga, Raghu Sinha, Esra Gov. A 19-Gene Signature of Serous Ovarian Cancer Identified by Machine Learning and Systems Biology: Prospects for Diagnostics and Personalized Medicine. OMICS: A Journal of Integrative Biology 2024; 28(2): 90 doi: 10.1089/omi.2023.0273
|
| 18 |
Aqsa Kanwal, Farrukh Azeem, Habibullah Nadeem, Usman Ali Ashfaq, Rana Muhammad Aadil, A. K. M. Humayun Kober, Muhammad Shahid Riaz Rajoka, Ijaz Rasul. Molecular Mechanisms of Cassia fistula against Epithelial Ovarian Cancer Using Network Pharmacology and Molecular Docking Approaches. Pharmaceutics 2022; 14(9): 1970 doi: 10.3390/pharmaceutics14091970
|
| 19 |
Irina Lojkin, Tami Rubinek, Sandra Orsulic, Omer Schwarzmann, Beth Y. Karlan, Shikha Bose, Ido Wolf. Reduced expression and growth inhibitory activity of the aging suppressor klotho in epithelial ovarian cancer. Cancer Letters 2015; 362(2): 149 doi: 10.1016/j.canlet.2015.03.035
|
| 20 |
HONGCHAO YAN, JIANYE TONG, XIAOMAN LIN, QIUYU HAN, HONGXIANG HUANG. Effect of the WWOX gene on the regulation of the cell cycle and apoptosis in human ovarian cancer stem cells. Molecular Medicine Reports 2015; 12(2): 1783 doi: 10.3892/mmr.2015.3640
|
| 21 |
Hongmei Li, Meihua Lv, Baohua Qiao, Xia Li. Blockade pf CD73/adenosine axis improves the therapeutic efficacy of docetaxel in epithelial ovarian cancer. Archives of Gynecology and Obstetrics 2019; 299(6): 1737 doi: 10.1007/s00404-019-05139-3
|
| 22 |
Megan A. Stewart, Taylor A. Rives, Kimberly Blanton, Lauren Baldwin. Mirvetuximab after anaphylaxis to Paclitaxel: A case report. Gynecologic Oncology Reports 2024; 54: 101452 doi: 10.1016/j.gore.2024.101452
|
| 23 |
Hale Guler Kara, Neslihan Pinar Ozates, Aycan Asik, Cumhur Gunduz. Cancer stemness kinase inhibitor amcasertib: a promising therapeutic agent in ovarian cancer stem and cancer cell models with different genetic profiles. Medical Oncology 2023; 40(12) doi: 10.1007/s12032-023-02210-7
|
| 24 |
Malak Itani, Neeraj Lalwani, Dhakshinamoorthy Ganeshan, Maria Zulfiqar, Cary Siegel. Current update on the molecular genetics and management of hereditary ovarian cancers: a primer for radiologists. Abdominal Radiology 2021; 46(6): 2281 doi: 10.1007/s00261-020-02911-x
|
| 25 |
Shruti Sanjay Taparia, Aparna Khanna. Procyanidin-rich extract of natural cocoa powder causes ROS-mediated caspase-3 dependent apoptosis and reduction of pro-MMP-2 in epithelial ovarian carcinoma cell lines. Biomedicine & Pharmacotherapy 2016; 83: 130 doi: 10.1016/j.biopha.2016.06.019
|
| 26 |
Krishnakumar Rajamani, Richard G. Moore, Sheena M. Stanard, Olga Astapova. Testosterone-Secreting Endometrioid Ovarian Carcinoma Presenting With Hyperandrogenism. AACE Clinical Case Reports 2022; 8(3): 135 doi: 10.1016/j.aace.2022.01.003
|
| 27 |
Burak Kucuk, Beyza Kibar, Ercan Cacan. A broad analysis in clinical and in vitro models on regulator of G‐protein signalling 10 regulation that is associated with ovarian cancer progression and chemoresistance. Cell Biochemistry and Function 2021; 39(3): 413 doi: 10.1002/cbf.3607
|
| 28 |
Clarissa L. Velayo, Kareen N. Reforma, Renee Vina G. Sicam, Michele H. Diwa, Alvin Duke R. Sy, Ourlad Alzeus G. Tantengco. Diagnostic Performances of Ultrasound-Based Models for Predicting Malignancy in Patients with Adnexal Masses. Healthcare 2022; 11(1): 8 doi: 10.3390/healthcare11010008
|
| 29 |
Silvia Breusa, Serena Zilio, Giuseppina Catania, Naoual Bakrin, David Kryza, Giovanna Lollo. Localized chemotherapy approaches and advanced drug delivery strategies: a step forward in the treatment of peritoneal carcinomatosis from ovarian cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1125868
|
| 30 |
Ewelina Piktel, Ilona Oscilowska, Łukasz Suprewicz, Joanna Depciuch, Natalia Marcińczyk, Ewa Chabielska, Przemysław Wolak, Katarzyna Głuszek, Justyna Klimek, Piotr M. Zieliński, Michał T. Marzec, Paul B. Savage, Magdalena Parlińska-Wojtan, Robert Bucki. Peanut-Shaped Gold Nanoparticles with Shells of Ceragenin CSA-131 Display the Ability to Inhibit Ovarian Cancer Growth In Vitro and in a Tumor Xenograft Model. Cancers 2021; 13(21): 5424 doi: 10.3390/cancers13215424
|
| 31 |
Zahraa Qusairy, Anne Gangloff, Shuk On Annie Leung. Dysregulation of Cholesterol Homeostasis in Ovarian Cancer. Current Oncology 2023; 30(9): 8386 doi: 10.3390/curroncol30090609
|
| 32 |
Adam C. Fields, Pamela W. Lu, George Z. Li, Vanessa Welten, Joshua S. Jolissaint, Benjamin M. Vierra, Lily V Saadat, Abby C. Larson, Rachel B. Atkinson, Nelya Melnitchouk. Current practices and future steps for hyperthermic intraperitoneal chemotherapy. Current Problems in Surgery 2020; 57(3): 100727 doi: 10.1016/j.cpsurg.2019.100727
|
| 33 |
Hongkai Shang, Jianfeng Zheng, Jinyi Tong. Integrated analysis of transcriptomic and metabolomic data demonstrates the significant role of pyruvate carboxylase in the progression of ovarian cancer. Aging 2020; 12(21): 21874 doi: 10.18632/aging.104004
|
| 34 |
Min-Hua Lai, Wen Jen Lin. Zein-PEG nanoparticles modified with hyaluronic acid for paclitaxel delivery in SKOV3 ovarian cancer cells. International Journal of Biological Macromolecules 2024; 281: 136651 doi: 10.1016/j.ijbiomac.2024.136651
|
| 35 |
Weiwei Zhang, Rong Liu, Chunhui Tang, Qinghua Xi, Shumin Lu, Wenjuan Chen, Lianxin Zhu, Jialin Cheng, Yannan Chen, Wei Wang, Jianxin Zhong, Yan Deng. PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer. International Journal of Biological Macromolecules 2016; 85: 405 doi: 10.1016/j.ijbiomac.2016.01.009
|
| 36 |
B.J. Dicken, D.F. Billmire, B. Rich, F.K. Hazard, M. Nuño, M. Krailo, N. Fallahazad, F. Pashankar, F. Shaikh, A.L. Frazier. Utility of frozen section in pediatric and adolescent malignant ovarian nonseminomatous germ cell tumors: A report from the children's oncology group. Gynecologic Oncology 2022; 166(3): 476 doi: 10.1016/j.ygyno.2022.06.013
|
| 37 |
Brenda Demacopulo, Baltazar Eduardo Lema, Rómulo Luis Cabrini, Erica Lorena Kreimann. Similar expression pattern of NHERF1 and EZRIN in papillary but not in solid areas of human serous ovarian carcinomas. Acta Histochemica 2016; 118(8): 797 doi: 10.1016/j.acthis.2016.10.002
|
| 38 |
Kouji Banno, Miho Iida, Megumi Yanokura, Haruko Irie, Kenta Masuda, Yusuke Kobayashi, Eiichiro Tominaga, Daisuke Aoki, Anish Bali. Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer. The Scientific World Journal 2015; 2015(1) doi: 10.1155/2015/341362
|
| 39 |
Ryan McWhorter, Massimo Libra, Benjamin Bonavida. Overcoming Cancers Resistant to HER-2 Antibodies. 2024; : 127 doi: 10.1016/B978-0-12-816408-2.00014-2
|
| 40 |
Yicong Wang, Lifeng Liu, Xianyu Jin, Yongai Yu. Efficacy and safety of mirvetuximab soravtansine in recurrent ovarian cancer with FRa positive expression: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology 2024; 194: 104230 doi: 10.1016/j.critrevonc.2023.104230
|
| 41 |
Andrzej Nowicki, Magdalena Kulus, Maria Wieczorkiewicz, Wojciech Pieńkowski, Katarzyna Stefańska, Paulina Skupin-Mrugalska, Rut Bryl, Paul Mozdziak, Bartosz Kempisty, Hanna Piotrowska-Kempisty. Ovarian Cancer and Cancer Stem Cells—Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology. Cancers 2021; 13(16): 4178 doi: 10.3390/cancers13164178
|
| 42 |
Elżbieta Supruniuk, Marta Baczewska, Ewa Żebrowska, Mateusz Maciejczyk, Kamil Klaudiusz Lauko, Patrycja Dajnowicz-Brzezik, Patrycja Milewska, Paweł Knapp, Anna Zalewska, Adrian Chabowski. Redox Biomarkers and Matrix Remodeling Molecules in Ovarian Cancer. Antioxidants 2024; 13(2): 200 doi: 10.3390/antiox13020200
|
| 43 |
Wenyu Li, Zheran Liu, Bowen Liang, Siyang Chen, Xinping Zhang, Xiaoqin Tong, Weiming Lou, Lulu Le, Xiaoli Tang, Fen Fu. Identification of core genes in ovarian cancer by an integrative meta-analysis. Journal of Ovarian Research 2018; 11(1) doi: 10.1186/s13048-018-0467-z
|
| 44 |
Deepak Parchwani, Sagar Jayantilal Dholariya, Sohil Takodara, Ragini Singh, Vivek Kumar Sharma, Alpana Saxena, Digishaben D. Patel, Madhuri Radadiya. Analysis of Prediagnostic Circulating Levels of Gonadotropins and Androgens with Risk of Epithelial Ovarian Cancer. Journal of Laboratory Physicians 2022; 14(01): 047 doi: 10.1055/s-0041-1741443
|
| 45 |
Ewelina Piktel, Ilona Ościłowska, Łukasz Suprewicz, Joanna Depciuch, Natalia Marcińczyk, Ewa Chabielska, Przemysław Wolak, Tomasz Wollny, Marianna Janion, Magdalena Parlinska-Wojtan, Robert Bucki. ROS-Mediated Apoptosis and Autophagy in Ovarian Cancer Cells Treated with Peanut-Shaped Gold Nanoparticles. International Journal of Nanomedicine 2021; : 1993 doi: 10.2147/IJN.S277014
|
| 46 |
Kathleen N Moore, Ignace Vergote, Ana Oaknin, Nicoletta Colombo, Susana Banerjee, Amit Oza, Patricia Pautier, Karim Malek, Michael J Birrer. FORWARD I: A Phase III Study of Mirvetuximab Soravtansine Versus Chemotherapy in Platinum-Resistant Ovarian Cancer. Future Oncology 2018; 14(17): 1669 doi: 10.2217/fon-2017-0646
|
| 47 |
Bryce Wallis, Katherine Redd Bowman, Phong Lu, Carol S. Lim. The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer. Biomolecules 2023; 13(1): 159 doi: 10.3390/biom13010159
|
| 48 |
J.N. Nikhitha, K.S. Swathy, R. Pratap Chandran. In vitro anticancer activity of ethanol extract of Adhatoda vasica Nees on human ovarian cancer cell lines. Journal of Genetic Engineering and Biotechnology 2021; 19(1): 116 doi: 10.1186/s43141-021-00215-1
|
| 49 |
Pei Du, Yifeng Wang, Liquan Chen, Yaping Gan, Qinian Wu. High ERCC1 expression is associated with platinum-resistance, but not survival in patients with epithelial ovarian cancer. Oncology Letters 2016; 12(2): 857 doi: 10.3892/ol.2016.4732
|
| 50 |
Mina Sharbatoghli, Parisa Shamshiripour, Fahimeh Fattahi, Elham Kalantari, Zohre Habibi Shams, Mahshid Panahi, Mehdi Totonchi, Zeynab Asadi-Lari, Zahra Madjd, Leili Saeednejad Zanjani. Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma. Journal of Ovarian Research 2022; 15(1) doi: 10.1186/s13048-021-00921-x
|
| 51 |
Iqra Yasin, Afshan Saeed Usmani, Jibran Mohsin, Rehan Bin Asif, Nazish Kahlid, Aamir Ali Syed. Prevalence and Risk Factors of Low Anterior Resection Syndrome in Epithelial Ovarian Cancer Surgery. Cureus 2022; doi: 10.7759/cureus.23180
|
| 52 |
Ying Wang, Chenming Yan, Junxia Qi, Chunyan Liu, Juan Yu, Huabin Wang. miR-874-3p mitigates cisplatin resistance through modulating NF-κB/inhibitor of apoptosis protein signaling pathway in epithelial ovarian cancer cells. Molecular and Cellular Biochemistry 2022; 477(1): 307 doi: 10.1007/s11010-021-04271-6
|
| 53 |
Nihar Godbole, Alexander Quinn, Flavio Carrion, Emanuele Pelosi, Carlos Salomon. Extracellular vesicles as a potential delivery platform for CRISPR-Cas based therapy in epithelial ovarian cancer. Seminars in Cancer Biology 2023; 96: 64 doi: 10.1016/j.semcancer.2023.10.002
|
| 54 |
Ahmed H.E. Hassan, Kyung-Tae Lee, Yong Sup Lee. Flavone-based arylamides as potential anticancers: Design, synthesis and in vitro cell-based/cell-free evaluations. European Journal of Medicinal Chemistry 2020; 187: 111965 doi: 10.1016/j.ejmech.2019.111965
|
| 55 |
Carlos Sanhueza, Joaquín Araos, Luciano Naranjo, Eric Barros, Lilian Toledo, Mario Subiabre, Fernando Toledo, Jaime Gutiérrez, Delia I. Chiarello, Fabián Pardo, Andrea Leiva, Luis Sobrevia. Are NHE1 and inducible nitric oxide synthase involved in human ovarian cancer?. Pharmacological Research 2016; 105: 183 doi: 10.1016/j.phrs.2016.01.007
|
| 56 |
Joanna Lopacinska-Jørgensen, Douglas V. N. P. Oliveira, Guy Wayne Novotny, Claus K. Høgdall, Estrid V. Høgdall, Klaus Roemer. Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer. PLOS ONE 2021; 16(7): e0255142 doi: 10.1371/journal.pone.0255142
|
| 57 |
Annamaria Sandomenico, Menotti Ruvo. Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers. Current Medicinal Chemistry 2019; 26(11): 1994 doi: 10.2174/0929867325666180912104707
|
| 58 |
Limin Xu, Susanna I. Lee, Aoife Kilcoyne. MR Imaging of Epithelial Ovarian Neoplasms Part II. Magnetic Resonance Imaging Clinics of North America 2023; 31(1): 53 doi: 10.1016/j.mric.2022.07.002
|
| 59 |
Antonino Bruno, Douglas M. Noonan, Roberto Valli, Giovanni Porta, Roberto Taramelli, Lorenzo Mortara, Francesco Acquati. Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer Pathogenesis. International Journal of Molecular Sciences 2022; 23(16): 9074 doi: 10.3390/ijms23169074
|
| 60 |
Sara Yaser Barham, Dorcas Omotade, Seda Yılmaz, Fatma Tuba Akdeniz, Betül Çapar Goralı, Rukset Attar, Turgay İsbir. Investigation of Polymorphisms in Global Genome Repair Genes in Patients With Ovarian Cancer in the Turkish Population. Cancer Control 2024; 31 doi: 10.1177/10732748241270597
|
| 61 |
Juwon Lee, Suin Jang, Jihye Im, Youngjin Han, Soochi Kim, HyunA Jo, Wenyu Wang, Untack Cho, Se Ik Kim, Aeran Seol, Boyun Kim, Yong Sang Song. Stearoyl-CoA desaturase 1 inhibition induces ER stress-mediated apoptosis in ovarian cancer cells. Journal of Ovarian Research 2024; 17(1) doi: 10.1186/s13048-024-01389-1
|
| 62 |
Deborah Gomez Kwolek, Stefanie Gerstberger, Sarah Tait, Jeanna M. Qiu. Ovarian, Uterine, and Vulvovaginal Cancers. Medical Clinics of North America 2023; 107(2): 329 doi: 10.1016/j.mcna.2022.10.016
|
| 63 |
Carlos Sanhueza, Joaquín Araos, Luciano Naranjo, Eric Barros, Mario Subiabre, Fernando Toledo, Jaime Gutiérrez, Delia I. Chiarello, Fabián Pardo, Andrea Leiva, Luis Sobrevia. Nitric oxide and pH modulation in gynaecological cancer. Journal of Cellular and Molecular Medicine 2016; 20(12): 2223 doi: 10.1111/jcmm.12921
|
| 64 |
Brahmana Askandar Tjokroprawiro, Khoirunnisa Novitasari, Renata Alya Ulhaq, Hanif Ardiansyah Sulistya. Clinicopathological analysis of giant ovarian tumors. European Journal of Obstetrics & Gynecology and Reproductive Biology: X 2024; 22: 100318 doi: 10.1016/j.eurox.2024.100318
|
| 65 |
Iana Garrick, Habiba Ahasan, Matthew Jiang, Yakubmiyer Musheyev, Farage Ftiha, Maria Levada. Fallopian Tube Originating Ovarian Cancer in a 53-Year-Old Postmenopausal Female With Hereditary Breast Cancer (BRCA) Genes: A Case Study. Cureus 2022; doi: 10.7759/cureus.23929
|
| 66 |
Aashna Patel, Roshni Kalachand, Steven Busschots, Ben Doherty, Evangelos Kapros, Denise Lawlor, Neville Hall, Britta K Stordal. Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer. Cochrane Database of Systematic Reviews 2022; 2022(7) doi: 10.1002/14651858.CD008766.pub3
|
| 67 |
Christine A. Prifti, Deborah Kwolek, Whitfield Board Growdon, Kerri Palamara. Sex- and Gender-Based Women's Health. 2020; : 231 doi: 10.1007/978-3-030-50695-7_15
|
| 68 |
Gyuntae Bae, Georgy Berezhnoy, André Koch, Claire Cannet, Hartmut Schäfer, Stefan Kommoss, Sara Brucker, Nicolas Beziere, Christoph Trautwein. Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1158330
|
| 69 |
Ya Liu, Xiaocui He, Yuli Chen, Dan Cao. Long non-coding RNA LINC00504 regulates the Warburg effect in ovarian cancer through inhibition of miR-1244. Molecular and Cellular Biochemistry 2020; 464(1-2): 39 doi: 10.1007/s11010-019-03647-z
|
| 70 |
Onur ERTUNÇ, Özlem ERDEM, Zümrüt Arda KAYMAK. CLINICOPATHOLOGIC VALUE OF IMMUNOHISTOCHEMICAL PINCH/LIMS-1 ANTIBODY EXPRESSION IN OVARIAN SEROUS CARCINOMA AND BORDERLINE SEROUS TUMOR. SDÜ Tıp Fakültesi Dergisi 2023; 30(3): 592 doi: 10.17343/sdutfd.1349330
|
| 71 |
Aydin Eresen. Leveraging Artificial Intelligence to Revolutionize Ovarian Cancer Diagnosis. Academic Radiology 2024; 31(6): 2402 doi: 10.1016/j.acra.2024.04.032
|
| 72 |
Liang Wang, Xite Lin, Pengming Sun. uPAR, beyond regulating physiological functions, has orchestrated roles in cancer (Review). International Journal of Oncology 2022; 61(6) doi: 10.3892/ijo.2022.5441
|
| 73 |
Boxiao Ding, Fang Yuan, Priyadarshan K. Damle, Larisa Litovchick, Ronny Drapkin, Steven R. Grossman. CtBP determines ovarian cancer cell fate through repression of death receptors. Cell Death & Disease 2020; 11(4) doi: 10.1038/s41419-020-2455-7
|
| 74 |
Sundaram Subramanian, Aseem Samar, Nisarg Joshi, Jaykumar Sejpal, Mujtaba Khan, Imran Ahmad. Efficacy and safety of nanosomal docetaxel lipid suspension based chemotherapy in metastatic ovarian carcinoma: A retrospective study. Molecular and Clinical Oncology 2021; 15(2) doi: 10.3892/mco.2021.2324
|
| 75 |
Paige G. Smith, Dana Roque, Mc Millan Ching, Amy Fulton, Gautam Rao, Jocelyn C. Reader. The Role of Eicosanoids in Gynecological Malignancies. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01233
|
| 76 |
Gerasimia Kirochristou, Stefanos K. Stefanou, Christos K. Stefanou, Stefanos Flindris, Thomas Tsiantis, Periklis Tsoumanis, Kostas Tepelenis. A case report of partial bowel obstruction as the first symptom of a sizeable adnexal mucinous cystadenoma. Innovative Surgical Sciences 2022; 7(2): 71 doi: 10.1515/iss-2022-0003
|
| 77 |
Diana Bužinskienė, Vilius Rudaitis, Karolina Misevičiūtė. Acute Presentation of Large Size Clear Cell Ovarian Carcinoma as Double Torsed Ovarian Tumor. Medicina 2022; 58(1): 89 doi: 10.3390/medicina58010089
|
| 78 |
Heba A.S. El-Nashar, Shaden Kocaeli, Mayar Abdallah, Mohamed El-Shazly. Marine Ecosystems: A Unique Source of Valuable Bioactive Compounds. Marine Ecology: Current and Future Developments 2023; : 355 doi: 10.2174/9789815051995123030013
|
| 79 |
Periklis Katopodis, Dimple Chudasama, Gurleen Wander, Louise Sales, Juhi Kumar, Manreen Pandhal, Vladimir Anikin, Jayanta Chatterjee, Marcia Hall, Emmanouil Karteris. Kinase Inhibitors and Ovarian Cancer. Cancers 2019; 11(9): 1357 doi: 10.3390/cancers11091357
|
| 80 |
Zhi Yong Shen, Ai Jun Shen, Shao Ling Yang, Ming Feng Wu. Combination of Sonographic Morphology Score and Tumor Markers for Detecting Postoperative Recurrent Pelvic Ovarian Carcinoma. Ultrasound Quarterly 2019; 35(1): 45 doi: 10.1097/RUQ.0000000000000394
|
| 81 |
Tomasz Ostrowski, Jakub Litwiński, Katarzyna Gęca, Izabela Świetlicka, Wojciech P. Polkowski, Magdalena Skórzewska. A Clinician's perspective on the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer management. Surgical Oncology 2024; 56: 102117 doi: 10.1016/j.suronc.2024.102117
|
| 82 |
Wei-Peng He, Gui-Ping Yang, Zun-Xian Yang, Hong-Wei Shen, Ze-Shan You, Guo-Fen Yang. Maelstrom promotes tumor metastasis through regulation of FGFR4 and epithelial-mesenchymal transition in epithelial ovarian cancer. Journal of Ovarian Research 2022; 15(1) doi: 10.1186/s13048-022-00992-4
|
| 83 |
Farzaneh Hamidi, Neda Gilani, Reza Arabi Belaghi, Parvin Sarbakhsh, Tuba Edgünlü, Pasqualina Santaguida. Exploration of Potential miRNA Biomarkers and Prediction for Ovarian Cancer Using Artificial Intelligence. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.724785
|
| 84 |
Yueh-Han Hsu, Peng-Hui Wang, Chia-Ming Chang. Functional Gene Clusters in Global Pathogenesis of Clear Cell Carcinoma of the Ovary Discovered by Integrated Analysis of Transcriptomes. International Journal of Environmental Research and Public Health 2020; 17(11): 3951 doi: 10.3390/ijerph17113951
|
| 85 |
Linjing Yuan, Jianxin Wan, Chumei Huang, Jingjing Liang, Min Liu, Caifeng Yue, Laisheng Li. Evaluation of serum CCL18 as a potential biomarker for ovarian cancer. Cancer Biomarkers 2017; 21(1): 97 doi: 10.3233/CBM-170305
|
| 86 |
Xianzhe Liu, Yan Gao, Jacson Shen, Wen Yang, Edwin Choy, Henry Mankin, Francis J. Hornicek, Zhenfeng Duan. Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel. Molecular Cancer Therapeutics 2016; 15(7): 1691 doi: 10.1158/1535-7163.MCT-16-0032
|
| 87 |
Ahmed Karam Farag, Ahmed H.E. Hassan, Kyung-Sook Chung, Jeong-Hun Lee, Hyo-Sun Gil, Kyung-Tae Lee, Eun Joo Roh. Diarylurea derivatives comprising 2,4-diarylpyrimidines: Discovery of novel potential anticancer agents via combined failed-ligands repurposing and molecular hybridization approaches. Bioorganic Chemistry 2020; 103: 104121 doi: 10.1016/j.bioorg.2020.104121
|
| 88 |
Boshu Sun, Liangliang Xu, Wenhui Bi, Wen-Bin Ou. SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance. International Journal of Molecular Sciences 2022; 23(4): 2053 doi: 10.3390/ijms23042053
|
| 89 |
R. Kar, J. K. Palanichamy, A. Banerjee, P. Chattopadhyay, S. K. Jain, N. Singh. Survivin siRNA increases sensitivity of primary cultures of ovarian cancer cells to paclitaxel. Clinical and Translational Oncology 2015; 17(9): 737 doi: 10.1007/s12094-015-1302-2
|
| 90 |
J Alejandro Perez-Fidalgo, Maria Iglesias, Uriel Bohn, Elisa Calvo, Yolanda Garcia, Eva Guerra, Luis Manso, Ana Santaballa, Antonio Gonzalez-Martin. GEICO1601-ROLANDO: A Multicentric Single Arm Phase II Clinical Trial to Evaluate the Combination of Olaparib and Pegylated Liposomal Doxorubicin for Platinum-Resistant Ovarian Cancer. Future Science OA 2019; 5(2) doi: 10.4155/fsoa-2018-0107
|
| 91 |
Sara Nasser, Khalid El Bairi, Dario Trapani, Boubacar Efared. Ovarian Cancer Biomarkers. 2021; : 1 doi: 10.1007/978-981-16-1873-4_1
|
| 92 |
Wei Wei, Yan Li, Shuqing Lv, Cancan Zhang, Yongjie Tian. PARP-1 may be involved in angiogenesis in epithelial ovarian cancer. Oncology Letters 2016; 12(6): 4561 doi: 10.3892/ol.2016.5226
|
| 93 |
Maja D. Nešić, Tanja Dučić, Branislava Gemović, Milan Senćanski, Manuel Algarra, Mara Gonçalves, Milutin Stepić, Iva A. Popović, Đorđe Kapuran, Marijana Petković. Prediction of Protein Targets in Ovarian Cancer Using a Ru-Complex and Carbon Dot Drug Delivery Therapeutic Nanosystems: A Bioinformatics and µ-FTIR Spectroscopy Approach. Pharmaceutics 2024; 16(8): 997 doi: 10.3390/pharmaceutics16080997
|
| 94 |
Changmei Liu, Fangmei Yang. Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma. Tumor Biology 2015; 36(9): 7213 doi: 10.1007/s13277-015-3437-8
|
| 95 |
Li Qiao, Xinhua Chen, Xuxia Xi, Xueqin Chen, Pengpeng Zhang, Hua Dong, Xiaohua Wu, Xiaojun Chen. Correlation analysis and clinical significance of CA125, HE4, DDI, and FDP in type II epithelial ovarian cancer. Medicine 2020; 99(49): e23329 doi: 10.1097/MD.0000000000023329
|
| 96 |
Suresh H. Advani, D. C. Doval, Smruti B. Koppikar, P. Vijay Anand Reddy, S. V. S. S. Prasad, Ajay Bapna, Prasad Narayanan, Amit Dutt Dwary, Vamshi Krishna, Manikandan Dhanushkodi, Anjana Joel, Unni S. Pillai, Kayathanahalli Govindachar Srinivas, Nagendra Ramanjinappa. Use of Bevacizumab in Advanced Ovarian Cancer: Consensus from an Expert Panel Oncologists. Indian Journal of Gynecologic Oncology 2021; 19(1) doi: 10.1007/s40944-020-00485-6
|
| 97 |
Renata Pavlič, Marija Gjorgoska, Tea Lanišnik Rižner. Model Cell Lines and Tissues of Different HGSOC Subtypes Differ in Local Estrogen Biosynthesis. Cancers 2022; 14(11): 2583 doi: 10.3390/cancers14112583
|
| 98 |
Meili Pa, Gulimire Naizaer, Ayinuer Seyiti, Gulina Kuerbang. RETRACTED ARTICLE: KDM3A confers metastasis and chemoresistance in epithelial ovarian cancer. Journal of Molecular Histology 2015; 46(6): 511 doi: 10.1007/s10735-015-9642-3
|
| 99 |
Shayna Sharma, Carlos Salomon. Biomarkers for Immunotherapy of Cancer. Methods in Molecular Biology 2020; 2055: 181 doi: 10.1007/978-1-4939-9773-2_8
|
| 100 |
Juran Kralj, Margareta Pernar Kovač, Sanja Dabelić, Darija Stupin Polančec, Thorsten Wachtmeister, Karl Köhrer, Anamaria Brozovic. Transcriptome analysis of newly established carboplatin-resistant ovarian cancer cell model reveals genes shared by drug resistance and drug-induced EMT. British Journal of Cancer 2023; 128(7): 1344 doi: 10.1038/s41416-023-02140-1
|
| 101 |
Kathleen N Moore, Lainie P Martin, David M O'Malley, Ursula A Matulonis, Jason A Konner, Ignace Vergote, Jose F Ponte, Michael J Birrer. A Review of Mirvetuximab Soravtansine in the Treatment of Platinum-Resistant Ovarian Cancer. Future Oncology 2018; 14(2): 123 doi: 10.2217/fon-2017-0379
|
| 102 |
Karen Rosnes Gissum. Precision Oncology and Cancer Biomarkers. Human Perspectives in Health Sciences and Technology 2022; 5: 69 doi: 10.1007/978-3-030-92612-0_6
|